NCT06854380View on ClinicalTrials.gov

Effect of Intralesional Injection of Corticosteroids Combined with Hyaluronidase in Treatment of Minimal Associated Pathological Lesions of Vocal Folds, Participants and Condition: Patients with Benign Vocal Fold Lesions, Intervention: Intralesional Injection Via Working Channel of Nasofiberscope

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 1, 2026

Primary Completion Date

July 1, 2026

Study Completion Date

October 1, 2026

Conditions
Voice and Voice Disorders
Interventions
DRUG

Intralesional injection of steroids (betamethasone), (Betafos®) and hyaluronidase (enzyme), (Hynidase®) into benign vocal fold lesions by a naso-fiberscope with a side working channel(Storz 11001UD1)

that this intervention is intralesional injection of glucocorticoid (betamethasone) and enzyme (hyaluronidase) via flexible fiberscope

Trial Locations (1)

35511

RECRUITING

Mansoura University - Faculty of Medicine, Al Mansurah

All Listed Sponsors
lead

Mansoura University

OTHER

NCT06854380 - Effect of Intralesional Injection of Corticosteroids Combined with Hyaluronidase in Treatment of Minimal Associated Pathological Lesions of Vocal Folds, Participants and Condition: Patients with Benign Vocal Fold Lesions, Intervention: Intralesional Injection Via Working Channel of Nasofiberscope | Biotech Hunter | Biotech Hunter